Mechanisms of vasodilation

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

A variety of factors interact to regulate vascular tone and thereby control blood flow to the regional circulations. The influx of calcium into vascular smooth muscle initiates contraction by binding to calmodulin and stimulating myosin light chain kinase. With the phosphorylation of the myosin light chain, myosin can interact with actin, hydrolyze ATP and produce contraction. Vascular relaxation can occur by reducing intracellular calcium or by dephosphorylating the myosin light chain. Endogenous vasodilators can promote vascular smooth muscle relaxation at three major sites, the noradrenergic nerve terminal, the smooth muscle cell, and the vascular endothelium. The release of norepinephrine from sympathetic nerves can be inhibited directly by the products of local metabolic activity and through the stimulation of a number of presynaptic receptors (for example, purinergic1, alpha2, cholinergic muscarinic). Many vasodilator agonists may use the endothelium to produce their effect (for example, acetylcholine, serotonin, thrombin, and the like). It is postulated that these agents cause endothelial calcium influx, thereby activating phospholipase to produce arachidonic acid, the majority of which is processed through the lipoxygenase pathway. It has been suggested that a lipoxygenase product stimulates the production of cyclic GMP, one controller of vascular smooth muscle calcium concentration. Each vascular bed has its own unique composition of local, neurogenic, and humoral blood flow regulatory mechanisms. Each vascular bed is also controlled by a broader integrated circulatory control scheme involving the central nervous system through reflex arcs and hormonal production. An understanding of the local factors regulating vascular tone, and how they are integrated within a global cardiocirculatory control system, is important in understanding at which points vasodilator drugs might be active. It has been proposed that the nitrates produce vasodilation by at least two mechanisms. The first involves production of nitric oxide, which can stimulate cyclic GMP production. The second involves inhibition of thromboxane synthetase, leading to preferential shunting of the products of cyclooxygenase activity toward the production of prostacyclin. Prostacyclin stimulates the formation of cyclic AMP which promotes vascular smooth muscle relaxation by reducing intracellular calcium ion and by promoting the phosphorylation of myosin light chain kinase thereby reducing its ability to be activated by calcium and calmodulin. The systemic response to nitrates is one of vasodilation, but the regional vascular responses depend on many factors, especially the presence of a disease process or physiologic stress that alters vascular tone.

Original languageEnglish (US)
Pages (from-to)3-12
Number of pages10
JournalThe American journal of medicine
Volume74
Issue number6 PART 2
DOIs
StatePublished - Jun 27 1983

Fingerprint

Vasodilation
Blood Vessels
Calcium
Vascular Smooth Muscle
Vasodilator Agents
Myosin-Light-Chain Kinase
Myosin Light Chains
Muscle Relaxation
Lipoxygenase
Cyclic GMP
Epoprostenol
Calmodulin
Nitrates
Cholinergic Agents
Phosphorylation
Thromboxane-A Synthase
Presynaptic Receptors
Aptitude
Phospholipases
Regional Blood Flow

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Zelis, Robert. / Mechanisms of vasodilation. In: The American journal of medicine. 1983 ; Vol. 74, No. 6 PART 2. pp. 3-12.
@article{a9e2ee53224a4bd3a3e4c27a7c0566ac,
title = "Mechanisms of vasodilation",
abstract = "A variety of factors interact to regulate vascular tone and thereby control blood flow to the regional circulations. The influx of calcium into vascular smooth muscle initiates contraction by binding to calmodulin and stimulating myosin light chain kinase. With the phosphorylation of the myosin light chain, myosin can interact with actin, hydrolyze ATP and produce contraction. Vascular relaxation can occur by reducing intracellular calcium or by dephosphorylating the myosin light chain. Endogenous vasodilators can promote vascular smooth muscle relaxation at three major sites, the noradrenergic nerve terminal, the smooth muscle cell, and the vascular endothelium. The release of norepinephrine from sympathetic nerves can be inhibited directly by the products of local metabolic activity and through the stimulation of a number of presynaptic receptors (for example, purinergic1, alpha2, cholinergic muscarinic). Many vasodilator agonists may use the endothelium to produce their effect (for example, acetylcholine, serotonin, thrombin, and the like). It is postulated that these agents cause endothelial calcium influx, thereby activating phospholipase to produce arachidonic acid, the majority of which is processed through the lipoxygenase pathway. It has been suggested that a lipoxygenase product stimulates the production of cyclic GMP, one controller of vascular smooth muscle calcium concentration. Each vascular bed has its own unique composition of local, neurogenic, and humoral blood flow regulatory mechanisms. Each vascular bed is also controlled by a broader integrated circulatory control scheme involving the central nervous system through reflex arcs and hormonal production. An understanding of the local factors regulating vascular tone, and how they are integrated within a global cardiocirculatory control system, is important in understanding at which points vasodilator drugs might be active. It has been proposed that the nitrates produce vasodilation by at least two mechanisms. The first involves production of nitric oxide, which can stimulate cyclic GMP production. The second involves inhibition of thromboxane synthetase, leading to preferential shunting of the products of cyclooxygenase activity toward the production of prostacyclin. Prostacyclin stimulates the formation of cyclic AMP which promotes vascular smooth muscle relaxation by reducing intracellular calcium ion and by promoting the phosphorylation of myosin light chain kinase thereby reducing its ability to be activated by calcium and calmodulin. The systemic response to nitrates is one of vasodilation, but the regional vascular responses depend on many factors, especially the presence of a disease process or physiologic stress that alters vascular tone.",
author = "Robert Zelis",
year = "1983",
month = "6",
day = "27",
doi = "10.1016/0002-9343(83)90848-3",
language = "English (US)",
volume = "74",
pages = "3--12",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "6 PART 2",

}

Mechanisms of vasodilation. / Zelis, Robert.

In: The American journal of medicine, Vol. 74, No. 6 PART 2, 27.06.1983, p. 3-12.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Mechanisms of vasodilation

AU - Zelis, Robert

PY - 1983/6/27

Y1 - 1983/6/27

N2 - A variety of factors interact to regulate vascular tone and thereby control blood flow to the regional circulations. The influx of calcium into vascular smooth muscle initiates contraction by binding to calmodulin and stimulating myosin light chain kinase. With the phosphorylation of the myosin light chain, myosin can interact with actin, hydrolyze ATP and produce contraction. Vascular relaxation can occur by reducing intracellular calcium or by dephosphorylating the myosin light chain. Endogenous vasodilators can promote vascular smooth muscle relaxation at three major sites, the noradrenergic nerve terminal, the smooth muscle cell, and the vascular endothelium. The release of norepinephrine from sympathetic nerves can be inhibited directly by the products of local metabolic activity and through the stimulation of a number of presynaptic receptors (for example, purinergic1, alpha2, cholinergic muscarinic). Many vasodilator agonists may use the endothelium to produce their effect (for example, acetylcholine, serotonin, thrombin, and the like). It is postulated that these agents cause endothelial calcium influx, thereby activating phospholipase to produce arachidonic acid, the majority of which is processed through the lipoxygenase pathway. It has been suggested that a lipoxygenase product stimulates the production of cyclic GMP, one controller of vascular smooth muscle calcium concentration. Each vascular bed has its own unique composition of local, neurogenic, and humoral blood flow regulatory mechanisms. Each vascular bed is also controlled by a broader integrated circulatory control scheme involving the central nervous system through reflex arcs and hormonal production. An understanding of the local factors regulating vascular tone, and how they are integrated within a global cardiocirculatory control system, is important in understanding at which points vasodilator drugs might be active. It has been proposed that the nitrates produce vasodilation by at least two mechanisms. The first involves production of nitric oxide, which can stimulate cyclic GMP production. The second involves inhibition of thromboxane synthetase, leading to preferential shunting of the products of cyclooxygenase activity toward the production of prostacyclin. Prostacyclin stimulates the formation of cyclic AMP which promotes vascular smooth muscle relaxation by reducing intracellular calcium ion and by promoting the phosphorylation of myosin light chain kinase thereby reducing its ability to be activated by calcium and calmodulin. The systemic response to nitrates is one of vasodilation, but the regional vascular responses depend on many factors, especially the presence of a disease process or physiologic stress that alters vascular tone.

AB - A variety of factors interact to regulate vascular tone and thereby control blood flow to the regional circulations. The influx of calcium into vascular smooth muscle initiates contraction by binding to calmodulin and stimulating myosin light chain kinase. With the phosphorylation of the myosin light chain, myosin can interact with actin, hydrolyze ATP and produce contraction. Vascular relaxation can occur by reducing intracellular calcium or by dephosphorylating the myosin light chain. Endogenous vasodilators can promote vascular smooth muscle relaxation at three major sites, the noradrenergic nerve terminal, the smooth muscle cell, and the vascular endothelium. The release of norepinephrine from sympathetic nerves can be inhibited directly by the products of local metabolic activity and through the stimulation of a number of presynaptic receptors (for example, purinergic1, alpha2, cholinergic muscarinic). Many vasodilator agonists may use the endothelium to produce their effect (for example, acetylcholine, serotonin, thrombin, and the like). It is postulated that these agents cause endothelial calcium influx, thereby activating phospholipase to produce arachidonic acid, the majority of which is processed through the lipoxygenase pathway. It has been suggested that a lipoxygenase product stimulates the production of cyclic GMP, one controller of vascular smooth muscle calcium concentration. Each vascular bed has its own unique composition of local, neurogenic, and humoral blood flow regulatory mechanisms. Each vascular bed is also controlled by a broader integrated circulatory control scheme involving the central nervous system through reflex arcs and hormonal production. An understanding of the local factors regulating vascular tone, and how they are integrated within a global cardiocirculatory control system, is important in understanding at which points vasodilator drugs might be active. It has been proposed that the nitrates produce vasodilation by at least two mechanisms. The first involves production of nitric oxide, which can stimulate cyclic GMP production. The second involves inhibition of thromboxane synthetase, leading to preferential shunting of the products of cyclooxygenase activity toward the production of prostacyclin. Prostacyclin stimulates the formation of cyclic AMP which promotes vascular smooth muscle relaxation by reducing intracellular calcium ion and by promoting the phosphorylation of myosin light chain kinase thereby reducing its ability to be activated by calcium and calmodulin. The systemic response to nitrates is one of vasodilation, but the regional vascular responses depend on many factors, especially the presence of a disease process or physiologic stress that alters vascular tone.

UR - http://www.scopus.com/inward/record.url?scp=0020532411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020532411&partnerID=8YFLogxK

U2 - 10.1016/0002-9343(83)90848-3

DO - 10.1016/0002-9343(83)90848-3

M3 - Article

VL - 74

SP - 3

EP - 12

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 6 PART 2

ER -